Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Integra LifeSciences Holdings Co (NASDAQ: IART) improved during the last several trading days. IART’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.
Recent Price Action
On 9/20/24, Integra LifeSciences Holdings Co (NASDAQ: IART) stock declined slightly by -0.4%, closing at $17.40. Moreover, exceptionally high trading volume at 201% of normal accompanied the decline. Relative to the market the stock has been extremely weak over the last nine months and has declined -1.4% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, IART is expected to continue to be an important Value Builder.
Integra LifeSciences Holdings has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Integra LifeSciences Holdings has a good Appreciation Score of 84 but a very low Power Rating of 2, resulting in the Low Neutral Value Trend Rating.
Be the first to comment